Ono Pharma to pay 28 bil. yen to settle patent suit with Nobel winner

Ono Pharmaceutical Co. said Friday it has agreed to pay 5 billion yen ($44 million) to Japanese Nobel laureate in medicine Tasuku Honjo and donate 23 billion yen to a research fund at his university to settle a lawsuit on cancer drug patent royalties. The settlement, reached at the Osaka District Court, resolves the suit in which Honjo, a distinguished professor at Kyoto University and 2018 Nobel Prize winner, had sought about 26.2 billion yen in patent royalties from the company that sells the cancer treatment drug Opdivo, developed based on discoveries by his research team. "We were able to reach a settlement I feel satisfied with. I would like to support fundamental research with the funds that we will get back from the company," Honjo said through his lawyer. In a news conference Friday, Ono Pharmaceutical President Gyo Sagara also welcomed the settlement, which he said "fully resolved" issues between the company and Honjo.

• Product Code
• ILEA000817415

• Registered date
• 2021/11/12 00:00:00

• Credit
• Kyodo / Kyodo News Images

• Media source
• Kyodo News

• Media size
• 1920 × 1080 pixel

• Deployment size
• 138.60(MB)*

• Special instruction

*File size when opened in Photoshop, etc.